CNS, oncology and HIV clinical trials: Current trends and future prospects

Phil Collis, Gordon McVie

Research output: Contribution to journalArticle

Abstract

Canvas opinion around the medical and scientific communities as to the therapeutic areas presenting the greatest challenges for the pharmaceutical industry in the 21st Century, and the chances are the CNS disease (a term covering a broad spectrum of pathologies), oncology and HIV infection will be at the top of many people's lists. Whilst some significant advances have occurred in these therapeutic areas over the last decade, the continuing morbidity and mortality associated with a diagnosis in these areas confirms the need for new therapies.

Original languageEnglish
Pages (from-to)102-106
Number of pages5
JournalEuropean Pharmaceutical Contractor
Issue numberSPRING
Publication statusPublished - Mar 2004

Fingerprint

Clinical Trials
HIV
Central Nervous System Diseases
Drug Industry
HIV Infections
Therapeutics
Pathology
Morbidity
Mortality

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

CNS, oncology and HIV clinical trials : Current trends and future prospects. / Collis, Phil; McVie, Gordon.

In: European Pharmaceutical Contractor, No. SPRING, 03.2004, p. 102-106.

Research output: Contribution to journalArticle

@article{a89df52b88ba43e7a65fe228650679c7,
title = "CNS, oncology and HIV clinical trials: Current trends and future prospects",
abstract = "Canvas opinion around the medical and scientific communities as to the therapeutic areas presenting the greatest challenges for the pharmaceutical industry in the 21st Century, and the chances are the CNS disease (a term covering a broad spectrum of pathologies), oncology and HIV infection will be at the top of many people's lists. Whilst some significant advances have occurred in these therapeutic areas over the last decade, the continuing morbidity and mortality associated with a diagnosis in these areas confirms the need for new therapies.",
author = "Phil Collis and Gordon McVie",
year = "2004",
month = "3",
language = "English",
pages = "102--106",
journal = "EPC - European Pharmaceutical Contractor",
issn = "1364-369X",
publisher = "Samedan Ltd",
number = "SPRING",

}

TY - JOUR

T1 - CNS, oncology and HIV clinical trials

T2 - Current trends and future prospects

AU - Collis, Phil

AU - McVie, Gordon

PY - 2004/3

Y1 - 2004/3

N2 - Canvas opinion around the medical and scientific communities as to the therapeutic areas presenting the greatest challenges for the pharmaceutical industry in the 21st Century, and the chances are the CNS disease (a term covering a broad spectrum of pathologies), oncology and HIV infection will be at the top of many people's lists. Whilst some significant advances have occurred in these therapeutic areas over the last decade, the continuing morbidity and mortality associated with a diagnosis in these areas confirms the need for new therapies.

AB - Canvas opinion around the medical and scientific communities as to the therapeutic areas presenting the greatest challenges for the pharmaceutical industry in the 21st Century, and the chances are the CNS disease (a term covering a broad spectrum of pathologies), oncology and HIV infection will be at the top of many people's lists. Whilst some significant advances have occurred in these therapeutic areas over the last decade, the continuing morbidity and mortality associated with a diagnosis in these areas confirms the need for new therapies.

UR - http://www.scopus.com/inward/record.url?scp=4444306707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444306707&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:4444306707

SP - 102

EP - 106

JO - EPC - European Pharmaceutical Contractor

JF - EPC - European Pharmaceutical Contractor

SN - 1364-369X

IS - SPRING

ER -